drugset / Trial / NCT02043340

Single Session Of Antimicrobial Photodynamic Therapy Using Indocyanine Green

NCT02043340

Phase 2 Completed 30 enrolled SVS Institute of Dental Sciences
NaSingle-groupDouble-blindTreatment

Summary

In recent years, there has been a growing interest in the use of dental lasers for treatment of periodontal diseases. Commercially available photodynamic therapy for periodontal diseases utilizes methylene blue as a photosensitizer. In this study, the effects of a novel photosensitizer dye, indocyanine green (ICG), as an adjunct to nonsurgical treatment of chronic periodontitis will be evaluated.

Timeline

Start
2012-10
Primary completion
2013-07
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 5 mg/ml

Indications